Cargando…
Neutrophil mediated smooth muscle cell loss precedes allograft vasculopathy
BACKGROUND: Cardiac allograft vasculopathy (AV) is a pathological process of vascular remodeling leading to late graft loss following cardiac transplantation. While there is consensus that AV is alloimmune mediated, and evidence that the most important alloimmune target is medial smooth muscle cells...
Autores principales: | King, Chelsey L, Devitt, Jennifer J, Lee, Timothy DG, Hancock Friesen, Camille L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909951/ https://www.ncbi.nlm.nih.gov/pubmed/20569484 http://dx.doi.org/10.1186/1749-8090-5-52 |
Ejemplares similares
-
Early innate immune events induced by prolonged cold ischemia exacerbate allograft vasculopathy
por: Devitt, Jennifer J, et al.
Publicado: (2011) -
Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015) -
α-Smooth Muscle Actin and ACTA2 Gene Expressions in
Vasculopathies
por: Yuan, Shi-Min
Publicado: (2015) -
Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Ellimuttil, Tracey M, et al.
Publicado: (2021) -
Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)